Cargando…
Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model
BACKGROUND: Marbofloxacin is a third-generation fluoroquinolone developed solely for veterinary medicine with a broad spectrum of antibacterial activity against some Gram-positive and most Gram-negative bacteria, including the bovine respiratory tract pathogen, Pasteurella multocida. The objective o...
Autores principales: | Qu, Ying, Qiu, Zhenzhen, Cao, Changfu, Lu, Yan, Sun, Meizhen, Liang, Chaoping, Zeng, Zhenling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668604/ https://www.ncbi.nlm.nih.gov/pubmed/26631082 http://dx.doi.org/10.1186/s12917-015-0608-1 |
Ejemplares similares
-
In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves
por: Cao, Changfu, et al.
Publicado: (2015) -
Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model
por: Zeng, Dongping, et al.
Publicado: (2018) -
Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling
por: Dorey, Lucy, et al.
Publicado: (2017) -
Integrated pharmacokinetic–Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets
por: Zeng, Qing Lin, et al.
Publicado: (2017) -
Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model
por: Yang, Qingwen, et al.
Publicado: (2019)